Aktiesnakken — Oktober 2010
-
Genmab med pæn overskrift: http://borsen.dk/nyheder/investor/artikel/1/194129/genmab_taet_paa_gennembrud_for_nyt_middel.html
-
så er vestas ude
-
3000 stillinger nedlægges....
-
140-160mio EUR i engangsomk.
-
Justeret herfor fastholder Vestas de i august udmeldte
forventninger til 2010 -
For 2011, hvor markeds¬usikkerheden og konkurrencen er
uændret stor, ventes indgangen af faste og ubetingede ordrer at blive
7.000-8.000 M -
Aktivitetsniveauet målt i producerede og afskibede MW ventes at
blive omkring 6.000 MW -
EBIT-marginen var 10,7 pct. mod 13,5 pct
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind